Joseph Caporusso

Gene therapy for diabetic foot ulcers: Interim analysis of a randomised, placebo‐controlled phase 3 study of VM202 (ENGENSIS), a plasmid DNA expressing two isoforms of human hepatocyte growth factor

David G Armstrong, E. Perin, J. Caporusso, 2023, International wound journal.